Ömer Faruk Hatipoğlu

990 total citations
49 papers, 761 citations indexed

About

Ömer Faruk Hatipoğlu is a scholar working on Molecular Biology, Rheumatology and Cancer Research. According to data from OpenAlex, Ömer Faruk Hatipoğlu has authored 49 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Rheumatology and 11 papers in Cancer Research. Recurrent topics in Ömer Faruk Hatipoğlu's work include Osteoarthritis Treatment and Mechanisms (11 papers), Protease and Inhibitor Mechanisms (7 papers) and Cell Adhesion Molecules Research (7 papers). Ömer Faruk Hatipoğlu is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (11 papers), Protease and Inhibitor Mechanisms (7 papers) and Cell Adhesion Molecules Research (7 papers). Ömer Faruk Hatipoğlu collaborates with scholars based in Japan, Türkiye and Germany. Ömer Faruk Hatipoğlu's co-authors include Satoshi Hirohata, Yoshifumi Ninomiya, Kadir Demircan, Kürşat Oğuz Yaykaşlı, Esra Gündüz, Toshitaka Oohashi, Shozo Kusachi, Ertuğrul Kaya, Hiroko Ogawa and Keiichiro Nishida and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ömer Faruk Hatipoğlu

47 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ömer Faruk Hatipoğlu Japan 18 312 213 181 113 96 49 761
Fei Zhu China 13 261 0.8× 212 1.0× 115 0.6× 71 0.6× 115 1.2× 21 782
Riccardo Chiusaroli United States 17 520 1.7× 124 0.6× 152 0.8× 157 1.4× 244 2.5× 22 898
Yi‐Chin Fong Taiwan 22 546 1.8× 124 0.6× 251 1.4× 106 0.9× 266 2.8× 35 1.1k
Adelheid Korb‐Pap Germany 14 481 1.5× 433 2.0× 152 0.8× 83 0.7× 204 2.1× 24 1.0k
Masashi Hatori Japan 14 345 1.1× 133 0.6× 167 0.9× 45 0.4× 171 1.8× 45 713
Céline Deroyer Belgium 11 387 1.2× 555 2.6× 229 1.3× 64 0.6× 78 0.8× 23 890
K. Graf Germany 13 586 1.9× 108 0.5× 171 0.9× 91 0.8× 106 1.1× 19 1.1k
Edith Charlier Belgium 11 413 1.3× 574 2.7× 224 1.2× 65 0.6× 77 0.8× 15 903
Naoya Suematsu Japan 17 345 1.1× 209 1.0× 115 0.6× 27 0.2× 61 0.6× 60 788
Amy J. Naylor United Kingdom 19 364 1.2× 129 0.6× 96 0.5× 49 0.4× 133 1.4× 39 870

Countries citing papers authored by Ömer Faruk Hatipoğlu

Since Specialization
Citations

This map shows the geographic impact of Ömer Faruk Hatipoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ömer Faruk Hatipoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ömer Faruk Hatipoğlu more than expected).

Fields of papers citing papers by Ömer Faruk Hatipoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ömer Faruk Hatipoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ömer Faruk Hatipoğlu. The network helps show where Ömer Faruk Hatipoğlu may publish in the future.

Co-authorship network of co-authors of Ömer Faruk Hatipoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Ömer Faruk Hatipoğlu. A scholar is included among the top collaborators of Ömer Faruk Hatipoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ömer Faruk Hatipoğlu. Ömer Faruk Hatipoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatipoğlu, Ömer Faruk, Takashi Nishinaka, Masahiro Nishibori, et al.. (2023). Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells. Journal of Pharmacological Sciences. 151(4). 177–186. 6 indexed citations
2.
Inagaki, Junko, Ömer Faruk Hatipoğlu, Ryosuke Ando, et al.. (2022). Potential of a Novel Chemical Compound Targeting Matrix Metalloprotease-13 for Early Osteoarthritis: An In Vitro Study. International Journal of Molecular Sciences. 23(5). 2681–2681. 6 indexed citations
3.
Watanabe, Masahiro, Takao Toyomura, Hidenori Wake, et al.. (2022). Nordihydroguaiaretic acid inhibits glyoxalase I, and causes the accumulation of methylglyoxal followed by cell-growth inhibition. Molecular Biology Reports. 49(11). 10499–10507.
4.
Nishinaka, Takashi, Ömer Faruk Hatipoğlu, Hidenori Wake, et al.. (2022). Glycolaldehyde-derived advanced glycation end products suppress STING/TBK1/IRF3 signaling via CD36. Life Sciences. 310. 121116–121116. 6 indexed citations
5.
Miyoshi, Toru, Kazufumi Nakamura, Ömer Faruk Hatipoğlu, et al.. (2022). LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats. Scientific Reports. 12(1). 4930–4930. 20 indexed citations
6.
Watanabe, Masahiro, Takao Toyomura, Hidenori Wake, et al.. (2022). Identification of ribosomal protein L9 as a novel regulator of proinflammatory damage-associated molecular pattern molecules. Molecular Biology Reports. 49(4). 2831–2838. 8 indexed citations
7.
Nishinaka, Takashi, Ömer Faruk Hatipoğlu, Hidenori Wake, et al.. (2021). Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages. PLoS ONE. 16(1). e0245957–e0245957. 9 indexed citations
8.
Wake, Hidenori, Takashi Nishinaka, Ömer Faruk Hatipoğlu, et al.. (2021). Involvement of multiple scavenger receptors in advanced glycation end product-induced vessel tube formation in endothelial cells. Experimental Cell Research. 408(1). 112857–112857. 10 indexed citations
9.
Hatipoğlu, Ömer Faruk, Hidenori Wake, Takashi Ohtsuki, et al.. (2021). Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial–mesenchymal transition. Biomedicine & Pharmacotherapy. 139. 111633–111633. 37 indexed citations
10.
Ohtsuki, Takashi, et al.. (2020). Induction of CEMIP in Chondrocytes by Inflammatory Cytokines: Underlying Mechanisms and Potential Involvement in Osteoarthritis. International Journal of Molecular Sciences. 21(9). 3140–3140. 17 indexed citations
11.
Hatipoğlu, Ömer Faruk, et al.. (2020). NF-ĸβ upregulates ADAMTS5 expression by direct binding after TNF-α treatment in OUMS-27 chondrosarcoma cell line. Molecular Biology Reports. 47(6). 4215–4223. 4 indexed citations
12.
Yaykaşlı, Kürşat Oğuz, et al.. (2017). Dose-dependent effects of adiponectin on ADAMTS-9 gene expression in human chondrocytes. Bratislavské lekárske listy/Bratislava medical journal. 118(7). 386–390. 2 indexed citations
13.
Nakamura, Kazufumi, Daiji Miura, Yukihiro Saito, et al.. (2017). Eicosapentaenoic acid prevents arterial calcification in klotho mutant mice. PLoS ONE. 12(8). e0181009–e0181009. 24 indexed citations
14.
Inagaki, Junko, Katsuyuki Takahashi, Hiroko Ogawa, et al.. (2014). ADAMTS1 inhibits lymphangiogenesis by attenuating phosphorylation of the lymphatic endothelial cell-specific VEGF receptor. Experimental Cell Research. 323(2). 263–275. 19 indexed citations
15.
Gündüz, Mehmet, Esra Gündüz, Levent Beder, et al.. (2012). Metastasis: Genetics, Mechanism, and Diagnostic and Therapeutic Strategies. Journal of Oncology. 2012. 1–2. 2 indexed citations
16.
Ogawa, Hiroko, Katsuyuki Takahashi, Jiayi Li, et al.. (2012). Tumor growth inhibitory effect of ADAMTS1 is accompanied by the inhibition of tumor angiogenesis. Cancer Science. 103(10). 1889–1897. 33 indexed citations
17.
Hatipoğlu, Ömer Faruk, et al.. (2012). Epigenetik Mekanizmalar ve Kanser. DergiPark (Istanbul University). 14(3). 58–68.
18.
Hekimsoy, Zeliha, et al.. (2012). 5-Alpha reductase type 2 deficiency: a case report. 15th International & 14th European Congress of Endocrinology. 29. 136576–136576. 1 indexed citations
19.
Katase, Naoki, Mehmet Gündüz, Levent Beder, et al.. (2008). Deletion at Dickkopf (Dkk)-3 Locus (11p15.2) Is Related With Lower Lymph Node Metastasis and Better Prognosis in Head and Neck Squamous Cell Carcinomas. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 17(6). 273–282. 22 indexed citations
20.
Nakamura, Keigo, Satoshi Hirohata, Ömer Faruk Hatipoğlu, et al.. (2005). Versican is induced in infiltrating monocytes in myocardial infarction. Molecular and Cellular Biochemistry. 280(1-2). 47–56. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fei Zhu Breakdown of academic impact, for papers by Riccardo Chiusaroli Breakdown of academic impact, for papers by Yi‐Chin Fong Breakdown of academic impact, for papers by Adelheid Korb‐Pap Breakdown of academic impact, for papers by Masashi Hatori Breakdown of academic impact, for papers by Céline Deroyer Breakdown of academic impact, for papers by K. Graf Breakdown of academic impact, for papers by Edith Charlier Breakdown of academic impact, for papers by Naoya Suematsu Breakdown of academic impact, for papers by Amy J. Naylor
Rankless by CCL
2026